KIEFFER TARA LYNN (Sr. VP, New Product Dev.) received a stock award from ENANTA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/13/2026ACC: 0002064832-26-000012
Officer· Sr. VP, New Product Dev.
Since Dec 2020
+3.31K
Net shares
Net buyer
$46.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
6.56K acquired · 3.26K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.57K
Price / share
—
Trade value
—
% of position
5.1%
2/12/2026
30.62K→32.20K
Common Stock
Direct
Shares
+4.99K
Price / share
—
Trade value
—
% of position
15.5%
2/12/2026
32.20K→37.18K
Common Stock
Direct
Shares
−3.26K
Price / share
$14.25
Trade value
$46.41K
% of position
8.8%
2/12/2026
37.18K→33.92K
Total
Net shares
+3.31K
Net value
-$46.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2026 | A · Award | +1.57K | — | — | 5.1% | 30.62K | 32.20K |
| Common Stock Direct | 2/12/2026 | A · Award | +4.99K | — | — | 15.5% | 32.20K | 37.18K |
| Common Stock Direct | 2/12/2026 | F · Tax Withholding | −3.26K | $14.25 | $46.41K | 8.8% | 37.18K | 33.92K |
| Total | +3.31K | -$46.41K | ||||||
Derivative Transactions0
No derivative transactions reported